University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Papers and Publications in Animal
Science

Animal Science Department

4-4-1994

Differential Regulation of Gonadotropin Synthesis and Release in
Ovariectomized Ewes after Treatment with a Luteinizing
Hormone-Releasing Hormone Antagonist
T. Sanchez
University of Nebraska-Lincoln

M. E. Wehrman
University of Nebraska-Lincoln

G. E. Moss
University of Wyoming, Laramie, Wyoming

F. N. Kojima
University of Nebraska-Lincoln

Andrea S. Cupp
University of Nebraska-Lincoln, acupp2@unl.edu
See next page for additional authors
Follow this and additional works at: https://digitalcommons.unl.edu/animalscifacpub
Part of the Animal Sciences Commons

Sanchez, T.; Wehrman, M. E.; Moss, G. E.; Kojima, F. N.; Cupp, Andrea S.; Bergfeld, E. G. M.; Peters, K. E.;
Mariscal, V.; Grotjan, H. E. Jr.; Kinder, J. E.; and Hamernik, D. L., "Differential Regulation of Gonadotropin
Synthesis and Release in Ovariectomized Ewes after Treatment with a Luteinizing Hormone-Releasing
Hormone Antagonist" (1994). Faculty Papers and Publications in Animal Science. 181.
https://digitalcommons.unl.edu/animalscifacpub/181

This Article is brought to you for free and open access by the Animal Science Department at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Papers and
Publications in Animal Science by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors
T. Sanchez, M. E. Wehrman, G. E. Moss, F. N. Kojima, Andrea S. Cupp, E. G. M. Bergfeld, K. E. Peters, V.
Mariscal, H. E. Grotjan Jr., J. E. Kinder, and D. L. Hamernik

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
animalscifacpub/181

BIOLOGY OF REPRODUCTION 51, 755-759 (1994)

Differential Regulation of Gonadotropin Synthesis and Release in Ovariectomized Ewes
after Treatment with a Luteinizing Hormone-Releasing Hormone Antagonist'
T. SANCHEZ, 3'4 M.E. WEHRMAN, 4 G.E. MOSS, 6 F.N. KOJIMA, 4 AS. CUPP, 4 E.G. BERGFELD,4 K.E. PETERS, 4
V. MARISCAL,4 H.E. GROTJAN, JR, 4 J.E. KINDER,2 '4 and D.L. HAMERNIKS

Departmentof Animal Science,4 University of Nebraska, Lincoln, Nebraska 68583-0908
Department of Veterinary and Biomedical Science,5 University of Nebraska, Lincoln, Nebraska 68583-0905
Department of Animal Science, 6 University of Wyoming, Laramie, Wyoming 82071
ABSTRACT
Our working hypothesis was that synthesis and release of LH, but not FSH, were solely dependent on LHRH. Twenty ovariectomized (OVX) ewes were randomly assigned to one of five treatments (n = 4 per group). Ewes were administered a low
(10 pg/kg) or high (100 g/kg) dose of LHRH antagonist (LHRH-Ant) at 24-h intervals for 3 or 6 days. Control ewes received
vehicle (5% mannitol) at 24-h intervals for 6 days. Blood samples were collected every 15 min for 4 h before LHRH-Ant or
vehicle and every 2 h during the period of treatment to determine concentrations of LH and FSH. Twenty-four hours after the
last treatment with LHRH-Ant or vehicle, anterior pituitaries were collected and divided in half along the midsagittal plane; the
number of receptors for LHRH, pituitary content of LH and FSH, and relative amounts of mRNA for ca, LHI1,and FSHP subunits
were determined. Concentrations of LH in serum decreased (p < 0.05) from 25.4 ± 4.3 ng/ml before LHRH-Ant to less than
0.5 ng/ml within 4 h after the first treatment of LHRH-Ant and remained low (< 0.5 ng/ml) throughout the study. Serum
concentrations of FSH declined gradually during the 3- or 6-day period of treatment with LHRH-Ant, from 37.3 ± 2.4 and 26.5
± 4.8 ng/ml to 19.9
1.8 and 13.7 ± 2.1 ng/ml, respectively. The magnitude of decline in serum concentrations of LH and
FSH did not differ among ewes treated with low or high doses of LHRH-Ant. Pituitary content of LH was not different (p > 0.10)
from that in controls, whereas pituitary content of FSH was greater (p < 0.01) in control ewes compared to ewes treated with
LHRH-Ant. Receptors for LHRH were nondetectable (< 0.018 x 10-16 mol receptor/tg protein) in pituitaries after 3 or 6 days
of treatment with LHRH-Ant (low or high dose). Relative amounts of mRNA for a, LHII, and FSHP subunits were lower (p <
0.01) after 6 days of treatment with LHRH-Ant (low or high dose) than after 3 days of treatment with LHRH-Ant (low or high
dose). The LHRH was, therefore, required to maintain steady state amounts of mRNA for FSH and LH and to maintain pituitary
stores of FSH but not LH. Our data support the hypothesis that differential regulation of LH and FSH release occurs in ewes.
While synthesis and release of LH are dependent on LHRH, synthesis but not release of FSH appears to be dependent on LHRH.

INTRODUCTION

After characterization of LHRH, it was widely accepted
that LHRH not only stimulates release of LH, but also FSH,
from gonadotrophs of the anterior pituitary [1]. There are
some reports suggesting that factors other than LHRH may
regulate release of FSH [2-5]. The role of LHRH in modulation of the release of FSH was questioned because decreased stimulation of the pituitary resulted in a greater decrease in release of LH than in release of FSH.
One method of studying the physiology of the isolated
pituitary gland is to actively immunize ovariectomized ewes
against LHRH to abolish the specific hypothalamic input. In
ovariectomized ewes immunized against LHRH, it has been
reported that the release of both LH and FSH is markedly
reduced [6].
Another method to isolate the pituitary from the influence of the hypothalamus is to perform the surgical proAccepted June 6, 1994.
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cedure of hypothalamic-pituitary disconnection. In sheep,
hypothalamic-pituitary disconnection leaves the primary
blood supply (superior hypophyseal arteries) to the pars
distalis intact, while the pituitary gland remains viable and
functions independently of hypothalamic input [7]. After hypothalamic-pituitary disconnection in ovariectomized ewes,
pituitary and serum concentrations of LH and FSH as well
as amounts of mRNA for the subunits of gonadotropins were
reported to decline within 3 days [4].
A third method for studying the physiology of the pituitary is through the use of antagonists against LHRH. Synthetic LHRH antagonists inhibit gonadotropin release by occupation of LHRH receptors on gonadotrophs [5, 8-10]. Use
of LHRH antagonists is advantageous to hypothalamic-pituitary disconnection because only LHRH inputs are blocked,
leaving the rest of the hypothalamic-pituitary axis intact. The
objective of the present study was to use an LHRH antagonist to determine the role of LHRH in the regulation of
synthesis and release of LH and FSH in ovariectomized ewes.
MATERIALS AND METHODS
Twenty crossbred ovariectomized ewes were randomly
assigned to one of five groups for treatment with either a
low (10 g/kg) or a high (100 Vzg/kg) dose of an LHRH
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TABLE 1. Concentrations of anterior pituitary receptors for LHRH.
Receptor concentrations
Treatment
Control

Ant-3Low
Ant-3High a
Ant-6Lowb
Ant-6Highb

(10-16 mol/ptg protein)
1.36 ±

d
0 .44

NDc
ND
ND
ND

aLow (10 pLg/kg) or High (100 pg/kg) concentration of LHRH-antagonist for
3 days.
bLow (10 Lg/kg) or High (100 g/kg) concentration of LHRH-antagonist for
6 days.
'ND = Nondetectable, <0.018 x 10-'6 mol receptor/pig protein.
dMean ± SEM.

antagonist (LHRH-Ant). The antagonist used in this study
was [N-Ac-D-Nal(2)'-4CI-D-Phe 2 , D-Pal(3) 3 -D-Cit6 , D-Ala'O]LHRH (SB-75). The LHRH-Ant was dissolved in 5% mannitol, and 1 ml was administered s.c. Ewes received the low
or high dose of LHRH-Ant every 24 h for 3 (n = 4; Ant3Low and Ant-3High, respectively) or 6 days (n = 4; Ant6Low and Ant-6High, respectively). Ewes in the control group
received sham injections (1 ml 5% mannitol) every 24 h
for 6 days. In sheep, the low concentration of LHRH-Ant (10
Rg/kg) had been shown previously to suppress release of
LH for 24 h when administered s.c. [11]. The high concentration of LHRH-Ant (100 g/kg) was used to ensure that
all receptors to LHRH would be occupied.
Blood samples were collected every 2 h from 4 h before
the initiation of treatment until 24 h after the last injection.
Blood was allowed to clot at room temperature and stored
at 4°C for 12 h; serum was then separated by centrifugation
at 1500 x g for 15 min. Serum was stored at -20°C until
assayed for LH and FSH.
Quantitation of LH [12] and FSH [13, 14] in serum and
pituitaries was by RIA. Intraassay coefficients of variation
were 4.3 and 4.2%, and interassay coefficients of variation
were 11.1 and 9.7% for LH and FSH, respectively.
Twenty-four hours after the last treatment with LHRHAnt, animals were administered 4 ml of phenobarbital to
achieve general anesthesia. Anterior pituitary glands were
collected immediately after exsanguination, divided in half
along the midsagittal plane, and stored at -70°C until subsequent analysis. Half of each anterior pituitary gland was
used to measure receptors for LHRH [15] and pituitary content of LH and FSH as described above. The remaining half
of each anterior pituitary gland was used to measure steady
state amounts of mRNA for aoand LHi subunits [16], and a
similar procedure was followed for FSHP subunit. The remaining half of each pituitary gland was used to isolate total
cellular RNA as described previously [4,16]. Five micrograms of total cellular RNA from individual hemipituitaries
was separated by electrophoresis through 1.5% agarose gels
containing formaldehyde and transferred to nylon membranes (Zeta-Probe GT; Bio-Rad Labs., Hercules, CA).
Radioactive cDNA probes for bovine a subunit [17], bovine LHI subunit [18], bovine FSH3 subunit [19], or rat cy-

clophilin [20] were prepared by random-primed labeling
[21]. Specific activity of all radioactive cDNA probes was approximately 2 x 109 dpm/,ig. Radioactive cDNA probes (106
cpm/ml; 10 ml/nylon membrane) were hybridized to total
cellular RNA on nylon membranes for at least 24 h at 42°C
and washed; specific radiolabeled bands were visualized by
autoradiography for 24-96 h at -70 0C [4]. The relative density of each band was quantitated by scanning densitometry
with a Visage 110 image analyzer (Eastman Kodak, Rochester, NY). Relative amounts of mRNA for gonadotropin
subunits were normalized to relative amounts of cyclophilin mRNA to correct for unequal loading of RNA [16].
Values are expressed as percentage of those measured in
ovariectomized, control ewes (ovariectomized = 100%).
Concentrations of LH and FSH in circulation before and
after treatment with LHRH-Ant, pituitary contents of LH and
FSH, and relative amounts of mRNA for gonadotropin subunits were examined by analysis of variance using the general linear models procedure of the SAS program [22]. Differences between treatment means were determined by
Fisher's least significant difference test [22, 23].
RESULTS

Receptors for LHRH in anterior pituitary glands were
nondetectable (< 0.018 x 10 - 16 mol receptor/g protein)
after 3 or 6 days of treatment with LHRH-Ant (either low
or high dose). Control ewes had 1.31 + 0.44 x 10 -16 mol
receptor/,ig protein (Table 1).
With both the low and high doses of LHRH-Ant, concentrations of LH in serum decreased (p < 0.01) from an average of 25.4 + 4.3 ng/ml before administration of LHRHAnt to less than 2.0 ng/ml within 8 h after the first treatment of LHRH-Ant (Fig. 1). Concentrations of LH remained
low (< 0.5 ng/ml) throughout the period (3 or 6 days) of
treatment (Table 2).
Concentrations of FSH in serum declined gradually, to
44% of the original concentration, in ewes from the Ant3Low and Ant-3High groups (Fig. 1). Similarly, there was a
52% decrease in concentrations of FSH in ewes treated with
low or high concentrations of LHRH-Ant for 6 days. The
magnitude of decline in serum concentrations of FSH did
not differ among ewes treated with the low vs. the high
dose of LHRH-Ant. Concentrations of FSH in serum after 3
or 6 days of treatment with LHRH-Ant were lower (p <
0.01) than in controls. Pituitary content (mg/pituitary) of
LH was not different (p > 0.05) in ewes treated with LHRHAnt compared to control ewes. Amounts of LH were, however, greater (p < 0.05) in ewes from the Ant-6Low (1.54
+ 0.44) group than in those from the Ant-6High group (0.71
+ 0.10). Pituitary content (mg/pituitary) of FSH was greater
(p < 0.01) in controls (0.75 - 0.25) than in ewes from the
Ant-3Low (0.13 ± 0.02), Ant-3High (0.19 ± 0.06), Ant-6Low
(0.14 - 0.04), and Ant-6High (0.14 - 0.04) groups (Fig. 2).
Steady state amounts of mRNA for a and LH subunits
were different (p < 0.01) among all treatment groups and
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FIG. 2. Pituitary content (mg/pituitary) of LH and FSH. Ant-3Low and
Ant-3High groups received 10 and 100 g/kg of LHRH antagonist for 3 days,
respectively. Ant-6Low and Ant-6High groups received 10 and 100 i±g/kg
of antagonist for 6 days, respectively. Control ewes received vehicle (1 ml
of 5% mannitol). a,b) Bars with different letters differ (p < 0.05).
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FIG. 1. Concentrations of LH and FSH during administration of LHRH
antagonist or vehicle. The top panel depicts mean concentrations of serum
FSH in control ewes (dashed line, OVX) and ewes in the Ant-6High group
(solid line). Mean concentrations of LH are depicted in the bottom panel
for control ewes (dashed line, OVX) and ewes in the Ant-6High group (solid
line). Ewes in the Ant-6 group were treated with 100 jwg/kg LHRH-Ant at
24-h intervals for 6 days.

were dose- and time-dependent (a: 36.33, 29.16, 18.25, and
12.13% of control for Ant-3Low, Ant-3High, Ant-6Low,
and Ant-6High groups, respectively; LH[:70.17, 68.37, 29.76,
and 25.50% of control for Ant-3Low, Ant-3High, Ant-6Low,
and Ant-6High, respectively). Amounts of mRNA for FSHP3
subunit were lower (p < 0.01) in pituitaries from all treatment groups compared to controls. Amounts of mRNA for
FSH[ also decreased in a dose- and time-dependent manner (79.59, 60.64, 67.10, and 36.04% of control for Ant-3Low,
Ant-3High, Ant-6Low, and Ant-6High treatments, respectively, Fig. 3).
DISCUSSION
Effects of LHRH on synthesis and release of LH and FSH
were examined by administering a low (10 Lg/kg) or a
high (100 g/kg) dose of LHRH-Ant for 3 or 6 days. The
low dose of LHRH-Ant had been previously used to suppress release of LH in wethers [11].
Receptors for LHRH were below the level of assay detection in ewes treated with either dose of LHRH-Ant in the
present study. The LHRH-Ant, SB-75, binds to a population
of high-affinity receptors for LHRH in membranes of pituitaries [24, 25]. Binding of SB-75 to receptors for LHRH in
pituitaries might influence the rate of turnover of the plasma
membrane [26] and the rate of internalization of LHRH receptors [27]. Prolonged treatment with SB-75 (60 days) was
reported to result in down-regulation of LHRH receptors in

anterior pituitary tissue [26]. Treatment with SB-75 in the
present study might have caused a down-regulation of LHRH
receptors that further resulted in a decreased stimulation
of gonadotrophs by endogenous LHRH. Consequently,
changes in amounts of mRNA for gonadotropin subunits,
content of pituitary gonadotropins, and concentrations of
gonadotropins in circulation can be explained by changes
in populations of LHRH receptors available to bind endogenous LHRH. Alternatively, LHRH receptors might have been
present in the plasma membranes of gonadotrophs but not
available to bind iodinated LHRH in the radioreceptor assay
because they were occupied by antagonist.
Release of LH was reduced to less than 2 ng/ml approximately 8 h after treatment with LHRH-Ant, and remained low throughout the treatment period. As a result

FIG. 3. Amounts of mRNA for a, LH[, and FSHP subunits. Values are
expressed as percentage of controls. Ant-3Low and Ant-3High groups received 10 and 100 pLg/kg of LHRH antagonist for 3 days, respectively. Ant6Low and Ant-6High groups received 10 and 100 g/kg of antagonist for
6 days, respectively. Control ewes received vehicle (1 ml of 5% mannitol).
a,b,c) Bars with different letters differ (p < 0.01).
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TABLE 2. Serum concentrations of LH and FSH (ng/ml) before and after treatment with LHRH-Ant.
Treatment

LH beforea

LH afterb

FSH before

FSH afterb

Control

14.7 + 1.2

13.62 + 3.13 C

40.0 + 8.9c

Ant-3Low

20.1 + 6.8

Ant-3High e
Ant-6Low f
Ant-6Highf

22.0 + 2.5
26.7 + 5.9
12.4 + 1.3

0.35 + 0 .15 d
0.20 + 0.11 d

39.3 - 9.0
28.9
2.0
37.3 3.0
31.1 + 2.0
27.6 + 3.0

0.37 + 0.13 d
0.30
0.09d

21.0

1.2

22.8 ± 3 7d
17.0 + 2.2d
13.8 4.1d

aSamples were collected every 15 min for 4 h before initiation of treatments with LHRH-antagonist or vehicle (Mean
± SEM).

bMean over a 10-h period (2-h samples starting 14 h after last treatment with LHRH-antagonist or vehicle).
c.dDifferent letters within the same column differ (p < 0.01).
eLow (10 ig/kg) or High (100 g/kg) concentration of LHRH-antagonist every 24 h for 3 days.
'Low (10 g/kg) or High (100 pg/kg) concentration of LHRH-antagonist every 24 h for 6 days.

of decreased LHRH stimulation of the gonadotrophs, suppressed release of LH was also reported in ovariectomized
rats [5] and intact male rats [2, 28] in which LHRH was immunoneutralized with ovine LHRH antisera and [29] in men
[30] and postmenopausal women [8] treated with an LHRH
antagonist. Continued release of LH, therefore, appears to
be dependent upon LHRH stimulation.
In contrast to LH, serum concentrations of FSH decreased only approximately 50% in the present study. A
similar observation was reported in male rats after administration of LHRH antagonist [2, 5, 28], in rats in which LHRH
was immunoneutralized with an ovine LHRH antiserum [29],
and in men [30] and postmenopausal women treated with
LHRH antagonist [8]. Basal release of FSH, therefore, appears to be only partially dependent upon stimulation by
LHRH.
Pituitary content of LH did not differ among animals
treated with LHRH-Ant compared to controls. In contrast,
pituitary content of FSH was reduced in all ewes treated
with LHRH. It is hypothesized that the decrease in pituitary
stores of FSH resulted from continued release of FSH. In
contrast, there was a 98% decrease in LH release, allowing
maintenance of pituitary stores of LH. Apparently, endogenous LHRH in ewes from the Ant-6High group was maximally decreased and the ewes responded to LHRH-Ant
treatment similarly to ewes with hypothalamic-pituitary disconnection [31].
A reduction in steady state amounts of mRNA for ct and
LH3 subunits occurred after treatment with LHRH-Ant in
the present investigation. A similar decrease in amounts of
a and LH3 subunits was observed previously in rats after
treatment with an antagonist of LHRH [5] and in hypothalamic-pituitary-disconnected ewes [4]. Amounts of mRNA for
FSHi subunit differed in ewes treated with LHRH-Ant compared to control ewes but were not decreased to the same
extent as ct and LH3 subunits. The reduction in steady state
amounts of mRNA for subunits of gonadotropins leads to
the suggestion that gonadotroph function requires continued inputs from the hypothalamus. Previous work [32] also
indicated that a pulsatile pattern of LHRH was needed to
stimulate transcription of gonadotropin subunit genes.

It has been hypothesized that factors other than LHRH
regulate the release of FSH [2-4,33]. Chronic inhibition of
pulsatile release of LHRH in intact ewes during the breeding season was reported to suppress amounts of FSH[3 subunit mRNA and release of FSH by 30 to 50%, but amounts
of LHP subunit mRNA and LH release were suppressed by
greater than 95% compared to control values [34]. Administration of LHRH antisera into the median eminence for 30
h failed to influence release of FSH but reduced release of
LH [35]. A single treatment of anestrous ewes with ovine
follicular fluid caused an initial suppression of FSH release
that was not affected by the acute blockade of LHRH [36].
It was suggested that a component of FSH release is independent of LHRH but that the subsequent enhanced release of FSH that follows this initial suppression may have
a component that is LHRH-dependent. The present experiment indicates that LHRH is necessary for synthesis of FSH
in ewes. Release of FSH appeared to decline only in association with decreased stores of FSH in the pituitary and
does not appear to be entirely dependent on LHRH. Our
data support the hypothesis that differential regulation of
LH and FSH release occurs in sheep. However, LHRH seems
to be required for maintenance of steady state amounts of
mRNA for the subunits of both pituitary gonadotropins.
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